PMID: 9443665Jan 27, 1998Paper

Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds: in vitro analyses

Antiviral Research
A S Mulato, J M Cherrington

Abstract

Adefovir (PMEA, 9-(2-phosphonomethoxyethyl)adenine), an acyclic nucleoside phosphonate analogue is active against retroviruses, hepadnaviruses and herpesviruses. Adefovir dipivoxil, an orally bioavailable prodrug of adefovir is currently in phase III clinical trials for the treatment of HIV and phase II clinical trials for the treatment of HBV infections. PMPA (9-(2-phosphonomethoxypropyl)adenine) is a related acyclic nucleoside phosphonate analogue that has demonstrated potent anti-SIV activity in rhesus macaques and recently has shown marked anti-HIV activity in a phase I clinical study. Since the standard of care for AIDS patients has become combination therapy, the effects of other antiretroviral compounds (d4T, ddC, AZT, ddI, 3TC, nelfinavir, ritonavir, indinavir, and saquinavir) on the anti-HIV activity of adefovir and PMPA were investigated in vitro. Adefovir and PMPA both demonstrated strong synergistic anti-HIV activity in combination with AZT. Adefovir demonstrated minor to moderate synergistic inhibition of HIV replication in combination with PMPA, d4T, ddC, nelfinavir, ritonavir, and saquinavir. PMPA demonstrated minor synergistic inhibition of HIV replication in combination with ddI and nelfinavir (and adefovir). A...Continue Reading

References

Oct 1, 1990·Antiviral Research·M N Prichard, C Shipman
Jul 1, 1988·Antimicrobial Agents and Chemotherapy·R PauwelsE De Clercq
Oct 2, 1986·Nature·E De ClercqP C Maudgal
Dec 7, 1995·The New England Journal of Medicine·M MarkowitzJ M Leonard
Apr 15, 1995·Lancet·V S KitchenJ N Weber
Jun 10, 1993·The New England Journal of Medicine·M S Hirsch, R T D'Aquila
Jun 15, 1996·Annals of Internal Medicine·J M SchapiroT C Merigan
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·J K WongD D Richman

❮ Previous
Next ❯

Citations

Jul 4, 2006·Indian Journal of Pediatrics·Pimpanada ChearskulBasim Asmar
Mar 6, 1999·Current Opinion in Microbiology·J BalzariniE De Clercq
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A O'Brien
Nov 9, 2004·International Journal of Clinical Practice·M Danta, G Dusheiko
Sep 8, 2011·Antimicrobial Agents and Chemotherapy·Karen Watson BuckheitRobert W Buckheit
Jan 5, 2006·Cerebrospinal Fluid Research·Christy AnthonypillaiSarah A Thomas
Jan 27, 2005·Drugs·Katherine A Lyseng-WilliamsonGreg L Plosker
Oct 16, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Damian J McCollMichael D Miller
Oct 4, 2003·Nature Reviews. Drug Discovery·William LewisWilliam C Copeland
Mar 1, 2007·The Journal of Antimicrobial Chemotherapy·Luigia RossiMauro Magnani
Dec 20, 2002·The Oncologist·Louis B HarrisonDaniel Shasha
May 21, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Keykavous ParangRakesh K Tiwari
Jul 31, 2003·Drugs·Therese ChapmanStuart Noble
Jun 22, 2007·Journal of Medicinal Chemistry·Ugo ChiacchioGiovanni Romeo
Jul 14, 2006·Antiviral Research·William A Lee, John C Martin
Mar 4, 2005·Journal of Medicinal Chemistry·Ugo ChiacchioGiovanni Romeo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.